Land: Armenien
Språk: engelska
Källa: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
butafosfan, vitamin B12
Interchemie werken De Adelaar Eesti AS
QA13A
butafosfan, vitamin B12
100mg/ml+50mcg/ml
solution for injection
glass bottle 100ml
Prescription
Registered
2015-06-09
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT: Marketing authorisation holder: Manufacturer and batch releaser: Interchemie werken “De Adelaar” B.V. Interchemie werken “De Adelaar” Eesti AS Metaalweg 8 Vanapere tee 14 5804 CG Venray Viimsi, Harju county The Netherlands Estonia NAME PRODUCT: Butasal-100. PHARMACEUTICAL FORM: A red solution for parenteral administration. STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S): Each ml contains: - ACTIVE SUBSTANCES: butafosfan 100 mg. cyanocobalamin (vitamin B 12 ) 50 μg. - EXCIPIENTS: benzyl alcohol 10.5 mg. INDICATIONS: Butasal-100 is indicated for debilitation by acute or chronic metabolism disorders that result from poor nutrition, inadequate management or disease (_e.g._ developmental and nutritional disorders in young animals due to rearing disease, and (secondary) ketosis in cows). It can be used for metaphylaxis of infertility, puerperal diseases and in support of sterility treatment. It acts as a roborant in cases of stress, overexertion, exhaustion and reduced resistance, and as a tonic in cases of weakness, secondary anaemia and chilling. Butasal-100 additionally supports muscular physiology, the treatment of infertility, and tetany and paresis as an adjunct to calcium and magnesium therapy. CONTRA-INDICATIONS: No contra-indications have been identified for Butasal-100 or any of its constituents. TARGET SPECIES: Cattle, calves, horses, foals, goats, kids, sheep, lambs, swine, piglets, poultry, dogs and cats. ADVERSE REACTIONS: No undesirable effects are known for this product. Butasal-100 is an extremely safe product. It can be used without any risk during gestation and lactation, evidenced by a milk withholding period of 0 days. There are no known toxic effects of overexposure to butafosfan or vitamin B12 in the quanities available in this formulation. Butasal-100 can be considered to be non-toxic. Care should be taken to avoid injection throu Läs hela dokumentet